Greenberg Traurig, LLP’s global Life Sciences & Medical Technology Group co-hosted the seminar, “Collaboration in Global Life Sciences,” with Korean law firm, Jipyong LLC, and German biotech strategy consulting firm, Catenion. The seminar took place from 2:00 – 5:30 p.m. on Oct. 22, 2019, at the Seoul International Dispute Resolution Center in Seoul, South Korea.
The event gathered Korean biotech, pharma, medical device, and medical technology companies for a series of presentations and a panel discussion focused on opportunities for collaboration in the emerging field of bioconvergence. Specific topics addressed the key factors in structuring and negotiating collaboration deals, IP and regulatory issues companies need to address in deal negotiations, and Korean legal issues that need to be considered when closing these deals.
- Seung Soo Choi, Partner, Jipyong LLC
- David J. Dykeman, patent attorney and co-chair of Greenberg Traurig’s global Life Sciences & Medical Technology Group and the Boston Intellectual Property & Technology (IP) Group
- Wayne H. Elowe, co-chair of Greenberg Traurig’s global Life Sciences & Medical Technology Group and co-chair of the firm’s Corporate Group in Atlanta
- Christian Elze, senior partner and founder, Catenion GmbH
- Bernard K. Ham, senior foreign attorney, Jipyong LLC
Jipyong Partner Tae Hyun Lee served as the moderator.
About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
Greenberg Traurig Seoul: Attorneys in Greenberg Traurig's Seoul office advise Korean, U.S., and other international clients with respect to both inbound and outbound matters. Our attorneys have decades of experience in areas including intellectual property litigation, commercial litigation, international arbitration, investments, tax, real estate, mergers and acquisitions, capital markets, antitrust, restructuring and reorganizations, international trade, structured products, and regulatory and commercial law.
About Greenberg Traurig: Greenberg Traurig, LLP (GT) has more than 2,000 attorneys in 39 offices in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.